The Gold Standard is a workplace- based program that focuses on lowering the risk of cancer.
Visit Website
The Life Sciences Consortium (LSC) brings together oncology companies to accelerate discovery and development of new therapies for all cancer patients. Visit Website
Allergan
American Century Investments
Aptuit
Astellas Pharma Inc.
AstraZeneca
Bayer HealthCare Pharmaceuticals Inc.
Blue Cross Blue Shield of North Carolina
Boehringer Ingelheim USA Corporation
C-Change
Celgene
Cigna Corporation
Covance
Duke University Health System
Eli Lilly and Company
EMD Serono
GlaxoSmithKline
Hatteras Venture Partners
Hogan Lovells US LLP
Independence Blue Cross
Johnson & Johnson
McKinsey & Company
MD Anderson Cancer Center
Merrimack Pharmaceuticals,Inc.
Millennium: The Takeda Oncology Company
Novartis
Pfizer, Inc.
PPD
Publicis Healthcare Communications Group
Quest Diagnostics
Quintiles Transnational
Sanofi
SAS Institute
State Farm Insurance Companies
The Livestrong Foundation
Valeant Pharmaceuticals International
Honorary Members
The CEO Roundtable on Cancer is proud to recognize the efforts of the following individuals who have worked to advance the mission of the Roundtable and are, therefore, welcomed as Honorary Members:
U.S. Government Organizations
The CEO Roundtable on Cancer is proud to work to fight cancer in collaboration with the following organizations within the United States Department of Health and Human Services:
US Department of Health and Human Services
National Cancer Institute (NCI)
Centers for Disease Control and Prevention (CDC)
Gold Standard accredited organization